Biogen Inc (BIIB)
207.13
+4.67
(+2.31%)
USD |
NASDAQ |
Apr 26, 11:20
Biogen Gross Profit Margin (Quarterly): 76.33% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 76.33% |
| December 31, 2023 | 74.09% |
| September 30, 2023 | 73.93% |
| June 30, 2023 | 75.87% |
| March 31, 2023 | 73.09% |
| December 31, 2022 | 77.56% |
| September 30, 2022 | 81.28% |
| June 30, 2022 | 81.31% |
| March 31, 2022 | 70.22% |
| December 31, 2021 | 75.85% |
| September 30, 2021 | 81.58% |
| June 30, 2021 | 83.43% |
| March 31, 2021 | 82.25% |
| December 31, 2020 | 82.80% |
| September 30, 2020 | 86.70% |
| June 30, 2020 | 88.83% |
| March 31, 2020 | 87.15% |
| December 31, 2019 | 87.82% |
| September 30, 2019 | 88.06% |
| June 30, 2019 | 86.83% |
| March 31, 2019 | 82.75% |
| December 31, 2018 | 86.15% |
| September 30, 2018 | 86.60% |
| June 30, 2018 | 87.46% |
| March 31, 2018 | 85.76% |
| Date | Value |
|---|---|
| December 31, 2017 | 84.60% |
| September 30, 2017 | 87.98% |
| June 30, 2017 | 88.10% |
| March 31, 2017 | 86.32% |
| December 31, 2016 | 86.82% |
| September 30, 2016 | 85.90% |
| June 30, 2016 | 87.21% |
| March 31, 2016 | 88.52% |
| December 31, 2015 | 88.31% |
| September 30, 2015 | 88.84% |
| June 30, 2015 | 88.96% |
| March 31, 2015 | 87.77% |
| December 31, 2014 | 88.74% |
| September 30, 2014 | 87.95% |
| June 30, 2014 | 87.95% |
| March 31, 2014 | 86.89% |
| December 31, 2013 | 86.85% |
| September 30, 2013 | 87.16% |
| June 30, 2013 | 86.61% |
| March 31, 2013 | 90.55% |
| December 31, 2012 | 90.56% |
| September 30, 2012 | 89.94% |
| June 30, 2012 | 90.21% |
| March 31, 2012 | 89.69% |
| December 31, 2011 | 93.24% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
70.22%
Minimum
Mar 2022
88.83%
Maximum
Jun 2020
80.75%
Average
81.44%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 80.88% |
| Bristol-Myers Squibb Co | 76.08% |
| Gilead Sciences Inc | 70.62% |
| AbbVie Inc | 60.11% |
| Regeneron Pharmaceuticals Inc | 84.95% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.02% |
| Return on Assets | 4.44% |
| Return on Invested Capital | 5.50% |
| Profit Margin (Quarterly) | 17.18% |
| Operating Margin (Quarterly) | 24.89% |
| Return on Net Operating Assets | 5.95% |